Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaideep Behari

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 18, 2022
The closing survival gap after liver transplantation for hepatocellular carcinoma in the United StatesHao Liu, Christof Kaltenmeier, Naudia Jonassaint, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
A metabolic-dysfunction associated steatotic liver acinus biomimetic induces pancreatic islet dysfunction in a coupled microphysiology systemJulio Aleman, K Ravikumar, Connor Wiegand, et al.
Journal of Hepatology|April 30, 2023
An individual patient data meta-analysis to determine cut-offs for and confounders of NAFLD-fibrosis staging with magnetic resonance elastographyJia-Xu Liang, Javier Ampuero, Hao Niu, et al.
Science Translational Medicine|November 4, 2011
Lipotoxicity causes multisystem organ failure and exacerbates acute pancreatitis in obesitySarah Navina, Chathur Acharya, James P DeLany, et al.
International Journal of Molecular Sciences|September 9, 2023
Evaluation of Human Hepatocyte Drug Metabolism Carrying High-Risk or Protection-Associated Liver Disease Genetic VariantsLanuza A P Faccioli, Zeliha Cetin, Zehra N Kocas-Kilicarslan, et al.
Metabolites|June 23, 2022
A Quantitative Systems Pharmacology Platform Reveals NAFLD Pathophysiological States and Targeting StrategiesDaniel E Lefever, Mark T Miedel, Fen Pei, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
Comparison of Wild-Type and High-risk PNPLA3 variants in a Human Biomimetic Liver Microphysiology System for Metabolic Dysfunction-associated Steatotic Liver Disease Precision TherapyMengying Xia, Maboubeh Varmazyad, Iris Pla Palacin, et al.
Frontiers in Cell and Developmental Biology|September 26, 2024
Comparison of wild-type and high-risk PNPLA3 variants in a human biomimetic liver microphysiology system for metabolic dysfunction-associated steatotic liver disease precision therapyMengying Xia, Mahboubeh Varmazyad, Iris Pla-Palacín, et al.
Digestive Diseases and Sciences|December 7, 2023
Limitations of Noninvasive Tests-Based Population-Level Risk Stratification Strategy for Nonalcoholic Fatty Liver DiseaseJaideep Behari, Allison Bradley, Kevin Townsend, et al.
Gastro Hep Advances|January 31, 2024
Polymorphisms Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease Influence the Progression of End-Stage Liver DiseaseZehra N Kocas-Kilicarslan, Zeliha Cetin, Lanuza A P Faccioli, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 18, 2022
The closing survival gap after liver transplantation for hepatocellular carcinoma in the United StatesHao Liu, Christof Kaltenmeier, Naudia Jonassaint, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
A metabolic-dysfunction associated steatotic liver acinus biomimetic induces pancreatic islet dysfunction in a coupled microphysiology systemJulio Aleman, K Ravikumar, Connor Wiegand, et al.
Journal of Hepatology|April 30, 2023
An individual patient data meta-analysis to determine cut-offs for and confounders of NAFLD-fibrosis staging with magnetic resonance elastographyJia-Xu Liang, Javier Ampuero, Hao Niu, et al.
Science Translational Medicine|November 4, 2011
Lipotoxicity causes multisystem organ failure and exacerbates acute pancreatitis in obesitySarah Navina, Chathur Acharya, James P DeLany, et al.
International Journal of Molecular Sciences|September 9, 2023
Evaluation of Human Hepatocyte Drug Metabolism Carrying High-Risk or Protection-Associated Liver Disease Genetic VariantsLanuza A P Faccioli, Zeliha Cetin, Zehra N Kocas-Kilicarslan, et al.
Metabolites|June 23, 2022
A Quantitative Systems Pharmacology Platform Reveals NAFLD Pathophysiological States and Targeting StrategiesDaniel E Lefever, Mark T Miedel, Fen Pei, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
Comparison of Wild-Type and High-risk PNPLA3 variants in a Human Biomimetic Liver Microphysiology System for Metabolic Dysfunction-associated Steatotic Liver Disease Precision TherapyMengying Xia, Maboubeh Varmazyad, Iris Pla Palacin, et al.
Frontiers in Cell and Developmental Biology|September 26, 2024
Comparison of wild-type and high-risk PNPLA3 variants in a human biomimetic liver microphysiology system for metabolic dysfunction-associated steatotic liver disease precision therapyMengying Xia, Mahboubeh Varmazyad, Iris Pla-Palacín, et al.
Digestive Diseases and Sciences|December 7, 2023
Limitations of Noninvasive Tests-Based Population-Level Risk Stratification Strategy for Nonalcoholic Fatty Liver DiseaseJaideep Behari, Allison Bradley, Kevin Townsend, et al.
Gastro Hep Advances|January 31, 2024
Polymorphisms Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease Influence the Progression of End-Stage Liver DiseaseZehra N Kocas-Kilicarslan, Zeliha Cetin, Lanuza A P Faccioli, et al.
Pageof 9